Table: Kubota Pharmaceutical Holdings -9-MTH group results (IFRS)

Kubota Pharmaceutical Holdings

14/11/2024 06:36

Nov 14 (Reuters)- 
              Kubota Pharmaceutical Holdings Co., Ltd. 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2024        Sep 30, 2023     Dec 31, 2024 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              17 mln              31 mln                     
                   (-43.9 pct)        (+965.5 pct)                  
  Operating       loss 955 mln          loss 1.03                   
  Pretax            loss 1.00           loss 1.03                   
  Net               loss 1.00           loss 1.03                   
  EPS Basic      loss 17.76 yen      loss 18.53 yen                 
  EPS Diluted    loss 17.76 yen      loss 18.53 yen                 
  Ann Div                                  NIL              NIL     
  -Q2 Div              NIL                 NIL                      
  -Q4 Div                                  NIL              NIL     
 
  NOTE - Kubota Pharmaceutical Holdings Co., Ltd.. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T